|
1
|
de Jesus GR, Agmon-Levin N, Andrade CA,
Andreoli L, Chighizola CB, Porter TF, Salmon J, Silver RM, Tincani
A and Branch DW: 14th International congress on antiphospholipid
antibodies task force report on obstetric antiphospholipid
syndrome. Autoimmun Rev. 13:795–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miyakis S, Lockshin MD, Atsumi T, Branch
DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni
PL, et al: International consensus statement on an update of the
classification criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gris JC and Bouvier S: Antiphospholipid
syndrome: Looking for a refocusing. Thromb Res 131 Suppl.
1:S28–S31. 2013. View Article : Google Scholar
|
|
4
|
Galli M, Borrelli G, Jacobsen EM, Marfisi
RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O and
Barbui T: Clinical significance of different antiphospholipid
antibodies in the WAPS (warfarin in the antiphospholipid syndrome)
study. Blood. 110:1178–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khamashta MA and Asherson RA: Hughes
syndrome: Antiphospholipid antibodies move closer to thrombosis in
1994. Br J Rheumatol. 34:493–494. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reverter JC, Tàssies D, Font J, Khamashta
MA, Ichikawa K, Cervera R, Escolar G, Hughes GR, Ingelmo M and
Ordinas A: Effects of human monoclonal anticardiolipin antibodies
on platelet function and on tissue factor expression on monocytes.
Arthritis Rheum. 41:1420–1427. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kornberg A, Blank M, Kaufman S and
Shoenfeld Y: Induction of tissue factor-like activity in monocytes
by anti-cardiolipin antibodies. J Immunol. 153:1328–1332.
1994.PubMed/NCBI
|
|
8
|
Branch DW and Rodgers GM: Induction of
endothelial cell tissue factor activity by sera from patients with
antiphospholipid syndrome: A possible mechanism of thrombosis. Am J
Obstet Gynecol. 168:206–210. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
López-Pedrera C, Cuadrado MJ, Herández V,
Buendïa P, Aguirre MA, Barbarroja N, Torres LA, Villalba JM,
Velasco F and Khamashta M: Proteomic analysis in monocytes of
antiphospholipid syndrome patients: Deregulation of proteins
related to the development of thrombosis. Arthritis Rheum.
58:2835–2844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruiz-Irastorza G and Khamashta MA:
Management of thrombosis in antiphospholipid syndrome and systemic
lupus erythematosus in pregnancy. Ann N Y Acad Sci. 1051:606–612.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Prima FA, Valenti O, Hyseni E, Giorgio
E, Faraci M, Renda E, De Domenico R and Monte S: Antiphospholipid
syndrome during pregnancy: The state of the art. J Prenat Med.
5:41–53. 2011.PubMed/NCBI
|
|
12
|
Meroni PL, Moia M, Derksen RH, Tincani A,
McIntyre JA, Arnout JM, Koike T, Piette JC, Khamashta MA and
Shoenfeld Y: Venous thromboembolism in the antiphospholipid
syndrome: Management guidelines for secondary prophylaxis. Lupus.
12:504–507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Erkan D, Ortel TL and Lockshin MD:
Warfarin in antiphospholipid syndrome-time to explore new horizons.
J Rheumatol. 32:208–212. 2005.PubMed/NCBI
|
|
14
|
Tincani A, Branch W, Levy RA, Piette JC,
Carp H, Rai RS, Khamashta M and Shoenfeld Y: Treatment of pregnant
patients with antiphospholipid syndrome. Lupus. 12:524–529. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marson P, Bagatella P, Bortolati M, Tison
T, De Silvestro G, Fabris F, Pengo V and Ruffatti A: Plasma
exchange for the management of the catastrophic antiphospholipid
syndrome: Importance of the type of fluid replacement. J Intern
Med. 264:201–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ibrahim RB and Balogun RA: Medications in
patients treated with therapeutic plasma exchange: Prescription
dosage, timing and drug overdose. Semin Dial. 25:176–189. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ibrahim RB and Balogun RA: Medications and
therapeutic apheresis procedures: Are we doing our best? J Clin
Apher. 28:73–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaplan AA: Therapeutic apheresis for renal
disorders. Therap Apher. 3:25–30. 1999. View Article : Google Scholar
|
|
19
|
Bove LL, Bednall T, Masser B and Buzza M:
Understanding the plasmapheresis donor in a voluntary,
nonremunerated environment. Transfusion. 51:2411–2424. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Crocco I, Franchini M, Garozzo G, Gandini
AR, Gandini G, Bonomo P and Aprili G: Adverse reactions in blood
and apheresis donors: Experience from two Italian transfusion
centres. Blood Transfus. 7:35–38. 2009.PubMed/NCBI
|
|
21
|
Nguyen TC, Kiss JE, Goldman JR and
Carcillo JA: The role of plasmapheresis in critical illness. Crit
Care Clin. 28:453–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakanishi T, Suzuki N, Kuragano T,
Nagasawa Y and Hasuike Y: Current topics in therapeutic
plasmapheresis. Clin Exp Nephrol. 18:41–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dittrich E, Schmaldienst S, Langer M,
Jansen M, Hörl WH and Derfler K: Immunoadsorption and plasma
exchange in pregnancy. Kidney Blood Press Res. 25:232–239. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bortolati M, Marson P, Chiarelli S, Tison
T, Facchinetti M, Gervasi MT, De Silvestro G and Ruffatti A: Case
reports of the use of immunoadsorption or plasma exchange in
high-risk pregnancies of women with antiphospholipid syndrome. Ther
Apher Dial. 13:157–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bontadi A, Ruffatti A, Marson P, Tison T,
Tonello M, Hoxha A, De Silvestro G and Punzi L: Plasma exchange and
immunoadsorption effectively remove antiphospholipid antibodies in
pregnant patients with antiphospholipid syndrome. J Clin Apher.
27:200–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrer DG, Jaldín-Fincati JR, Amigone JL,
Capra RH, Collino CJ, Albertini RA and Chiabrando GA: Standardized
flow cytometry assay for identification of human monocytic
heterogeneity and LRP1 expression in monocyte subpopulations:
Decreased expression of this receptor in nonclassical monocytes.
Cytometry A. 85:601–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manukyan G, Petrek M, Kriegova E,
Ghazaryan K, Fillerova R, Fillerova R and Boyajyan A: Activated
phenotype of circulating neutrophils in familial mediterranean
fever. Immunobiology. 218:892–898. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cuadrado MJ, López-Pedrera C, Khamashta
MA, Camps MT, Tinahones F, Torres A, Hughes GR and Velasco F:
Thrombosis in primary antiphospholipid syndrome: A pivotal role for
monocyte tissue factor expression. Arthritis Rheum. 40:834–841.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wakefield TW, Strieter RM, Wilke CA,
Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL and
Greenfield LJ: Venous thrombosis-associated inflammation and
attenuation with neutralizing antibodies to cytokines and adhesion
molecules. Arterioscler Thromb Vasc Biol. 15:258–268. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Godessart N and Kunkel SL: Chemokines in
autoimmune disease. Curr Opin Immunol. 13:670–675. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oghumu S, Lezama-Dávila CM, Isaac-Márquez
AP and Satoskar AR: Role of chemokines in regulation of immunity
against leishmaniasis. Exp Parasitol. 126:389–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gu D, Chen Z, Zhao H, Du W, Xue F, Ge J,
Sui T, Wu H, Liu B, Lu S, Zhang L and Yang R: Th1 (CXCL10) and Th2
(CCL2) chemokine expression in patients with immune
thrombocytopenia. Hum Immunol. 71:586–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rotondi M, Rosati A, Buonamano A, Lasagni
L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La
Villa G, et al: High pretransplant serum levels of CXCL10/IP-10 are
related to increased risk of renal allograft failure. Am J
Transplant. 4:1466–1474. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wegmann TG, Lin H, Guilbert L and Mosmann
TR: Bidirectional cytokine interactions in the maternal-fetal
relationship: Is successful pregnancy a TH2 phenomenon? Immunology
Today. 14:353–356. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lissauer D, Goodyear O, Khanum R, Moss PA
and Kilby MD: Profile of maternal CD4 T-cell effector function
during normal pregnancy and in women with a history of recurrent
miscarriage. Clin Sci (Lond). 126:347–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Raghupathy R, Makhseed M, Azizieh F, Omu
A, Gupta M and Farhat R: Cytokine production by maternal
lymphocytes during normal human pregnancy and in unexplained
recurrent spontaneous abortion. Hum Reprod. 15:713–778. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bernales I, Fullaondo A, Marín-Vidalled
MJ, Ucar E, Martínez-Taboada V, López-Hoyos M and Zubiaga AM:
Innate immune response gene expression profiles characterize
primary antiphospholipid syndrome. Genes Immun. 9:38–46. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Laird SM, Tuckerman EM, Cork BA, Linjawi
S, Blakemore AI and Li TC: A review of immune cells and molecules
in women with recurrent miscarriage. Hum Reprod Update. 9:163–174.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Goto H, Matsuo H, Nakane S, Izumoto H,
Fukudome T, Kambara C and Shibuya N: Plasmapheresis affects T
helper type-1/T helper type-2 balance of circulating peripheral
lymphocytes. Ther Apher. 5:494–496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shariatmadar S, Nassiri M and Vincek V:
Effect of plasma exchange on cytokines measured by multianalyte
bead array in thrombotic thrombocytopenic purpura. Am J Hematol.
79:83–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Haskill S, Johnson C, Eierman D, Becker S
and Warren K: Adherence induces selective mRNA expression of
monocyte mediators and proto-oncogenes. J Immunol. 140:1690–1694.
1988.PubMed/NCBI
|
|
43
|
Fuhlbrigge RC, Chaplin DD, Kiely JM and
Unanue ER: Regulation of interleukin 1 gene expression by adherence
and lipopolysaccharide. J Immunol. 138:3799–3802. 1987.PubMed/NCBI
|
|
44
|
Yang J, Hooper WC, Phillips DJ, Tondella
ML and Talkington DF: Centrifugation of human lung epithelial
carcinoma a549 cells up-regulates interleukin-1beta gene
expression. Clin Diagn Lab Immunol. 9:1142–1143. 2002.PubMed/NCBI
|
|
45
|
Yona S and Jung S: Monocytes: subsets,
origins, fates and functions. Curr Opin Hematol. 17:53–59. 2010.
View Article : Google Scholar : PubMed/NCBI
|
